Enraf-Nonius Belux SRL
3.2 FTEEnraf-Nonius Belux reported total assets of 99,154 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026), with 3.2 full-time equivalents.
The score of Enraf-Nonius Belux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Enraf-Nonius Belux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
Enraf-Nonius Belux's financial analysis
- Solvency-56.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Enraf-Nonius Belux
Enraf-Nonius Belux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0798.399.080
- VAT number
- BE0798399080
- Peppol
- Registered · 0208:0798399080 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Feb 2023
- Registered office
- 2390 Malle
- Size
- Micro · 3.2 FTE
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Enraf-Nonius Belux (SRL) has been based in Malle since 2023, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 48,185 € and equity of −55,501 €; its revenue is not published. With 3.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -56.0%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Enraf-Nonius Belux
Companies in the same business, of comparable size and area, outside its group.
- Vinterno Wholesale of pharmaceutical and medical goods Kalmthout · balance sheet 153,990 €
- Revalidation et Materiel Paramedical Wholesale of pharmaceutical and medical goods Pont-à-Celles · balance sheet 43,450 €
- BTL Belgium Wholesale of pharmaceutical and medical goods Kontich · balance sheet 136,557 €
- UNI-COM Wholesale of pharmaceutical and medical goods Woluwe-Saint-Pierre · balance sheet 145,009 €
- Verimed Medical Supply Wholesale of pharmaceutical and medical goods Wetteren · balance sheet 90,302 €
- Cumerco Wholesale of pharmaceutical and medical goods Wellen · balance sheet 60,095 €
- HCPS Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 80,577 €
- MD Medic Wholesale of pharmaceutical and medical goods Ghent · balance sheet 369,386 €
Frequently asked questions about Enraf-Nonius Belux
What is the revenue of Enraf-Nonius Belux?
Enraf-Nonius Belux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Enraf-Nonius Belux?
In Belgium, the VAT number is the company number prefixed with BE: BE0798399080 for Enraf-Nonius Belux, if the company is VAT-registered. Its company number (CBE) is 0798.399.080.
Where is the registered office of Enraf-Nonius Belux?
According to the CBE register, the registered office of Enraf-Nonius Belux is in 2390 Malle.
What is the equity of Enraf-Nonius Belux?
At the close of the 2025 financial year, the equity of Enraf-Nonius Belux amounts to -55,501 €, a solvency of -56.0% of total assets.
How many people work at Enraf-Nonius Belux?
3.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Enraf-Nonius Belux?
The register lists 6 active mandates at Enraf-Nonius Belux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Enraf-Nonius Belux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →